Literature DB >> 32771211

Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge.

Joshua J X Li1, Gary M Tse2.   

Abstract

Fibroepithelial lesions (FEL) of the breast are biphasic neoplasms consisting of proliferative epithelial and stromal components and include fibroadenoma, phyllodes tumour and periductal stromal tumour. Core needle biopsy (CNB) is a commonly used diagnostic modality for investigation of breast lesions. As the accurate diagnosis of FEL requires integrated assessment of both epithelial and stromal components, this may create problems in small biopsies with limited sampling. In this review, common problems encountered in CNB of FEL are discussed, including establishing a diagnosis of borderline/malignant phyllodes tumour in a biopsy consisting of malignant spindle cells, differentiating phyllodes tumour from fibroadenoma on CNB, grading of phyllodes tumour of intermediate histological grade and assessment of periductal stromal tumours. The approaches are detailed systematically based on histology, immunohistochemistry and molecular characterisation. This comprehensive approach may aid in dealing with the overlapping histological appearance of FEL and sampling limitations of CNB.
Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibroepithelial lesion; breast; fibroadenoma; phyllodes tumour

Mesh:

Year:  2020        PMID: 32771211     DOI: 10.1016/j.pathol.2020.06.005

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  The value of whole-tumor histogram and texture analysis based on apparent diffusion coefficient (ADC) maps for the discrimination of breast fibroepithelial lesions: corresponds to clinical management decisions.

Authors:  Xue Li; Weimin Chai; Kun Sun; Caixia Fu; Fuhua Yan
Journal:  Jpn J Radiol       Date:  2022-07-06       Impact factor: 2.374

2.  Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial.

Authors:  Sadaf Alipour; Mahboubeh Abedi; Azin Saberi; Arezoo Maleki-Hajiagha; Firoozeh Faiz; Saeed Shahsavari; Bita Eslami
Journal:  BMC Endocr Disord       Date:  2021-08-20       Impact factor: 2.763

3.  Current classification systems and standardized terminology in cytopathology.

Authors:  Tibor Mezei
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.